RESULTS	The corresponding figures , after exclusion of the patients with opposite-breast and skin tumors , were : untreated patients : 2 % ( 95 % CI : 0.6 % -3.4 % ) ; tamoxifen-treated patients : 0.95 % ( 95 % CI : 0.0 % -2.4 % ) ; chemotherapy-treated patients : 2.6 % ( 95 % CI : 0.4 % -4.8 % ) ; chemotherapy plus tamoxifen : 1.65 % ( 95 % CI : 0.4 % -3.8 % ) ; ( all groups : P = n.s. ; CT versus TAM P = 0.05 ) .\